Login to Your Account



Biofirms See Rare Diseases Initiative as Lever on Pricing

By Peter O'Donnell


Wednesday, November 19, 2008
No Abstract

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription